跳至主要内容
临床试验/JPRN-UMIN000049726
JPRN-UMIN000049726尚未招募Unknown

Prospective observational study on pain relief, functional evaluation and safety of human adipose-derived mesenchymal stem cell culture supernatant solution for acute and chronic pain Singl-center, single-arm open study - MSC-CM Trial

General incorporated association Advalife Science SINCLAIR GINZA CLINIC0 个研究点目标入组 30 人开始时间: 2022年12月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have taken anti-inflammatory analgesics within 8 hours prior to the administration of the study drug 2. Patients who have used sleeping pills, psychotropic drugs, or other psychiatric drugs within 24 hours prior to administration of the study drug 3. Patients suffering from infectious diseases 4. Patients with a history of cancer or active malignancy 5. Patients with hypoglycemic symptoms prior to administration of the study drug 6. Patients who are judged to be inappropriate as research subjects by the principal investigator and principal study investigator

研究者

发起方
General incorporated association Advalife Science SINCLAIR GINZA CLINIC

相似试验

Prospective observational study on pain relief,... | 临床试验